Henri Wichmann

671 total citations
20 papers, 561 citations indexed

About

Henri Wichmann is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Henri Wichmann has authored 20 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Henri Wichmann's work include Cancer, Hypoxia, and Metabolism (6 papers), Bone and Dental Protein Studies (4 papers) and Enzyme function and inhibition (3 papers). Henri Wichmann is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Bone and Dental Protein Studies (4 papers) and Enzyme function and inhibition (3 papers). Henri Wichmann collaborates with scholars based in Germany, Pakistan and France. Henri Wichmann's co-authors include Dirk Vordermark, Matthias Bache, Matthias Kappler, Jacqueline Keßler, Swetlana Rot, Helge Täubert, Antje Güttler, Thomas Greither, Matthias Kotzsch and Reinhard Paschke and has published in prestigious journals such as Clinical Cancer Research, International Journal of Molecular Sciences and BMC Bioinformatics.

In The Last Decade

Henri Wichmann

20 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henri Wichmann Germany 16 375 202 107 91 74 20 561
Antje Güttler Germany 14 242 0.6× 114 0.6× 72 0.7× 62 0.7× 77 1.0× 24 379
Maria Serena Roca Italy 14 457 1.2× 152 0.8× 184 1.7× 104 1.1× 29 0.4× 28 709
Filipa Lopes‐Coelho Portugal 11 358 1.0× 251 1.2× 135 1.3× 79 0.9× 25 0.3× 17 634
Zengxia Li China 21 625 1.7× 172 0.9× 153 1.4× 55 0.6× 22 0.3× 38 895
Marike W. van Gisbergen Netherlands 14 315 0.8× 207 1.0× 61 0.6× 68 0.7× 15 0.2× 20 508
Ann Greer United States 15 516 1.4× 181 0.9× 198 1.9× 133 1.5× 26 0.4× 20 832
Sonia Dolfi United States 14 431 1.1× 223 1.1× 289 2.7× 56 0.6× 21 0.3× 33 756
Jacqueline Sayyah United States 9 368 1.0× 78 0.4× 178 1.7× 47 0.5× 67 0.9× 11 534
Joon Hee Kang South Korea 15 349 0.9× 297 1.5× 77 0.7× 78 0.9× 45 0.6× 27 577
Thomas H. Beckham United States 16 503 1.3× 74 0.4× 143 1.3× 84 0.9× 28 0.4× 44 758

Countries citing papers authored by Henri Wichmann

Since Specialization
Citations

This map shows the geographic impact of Henri Wichmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Wichmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Wichmann more than expected).

Fields of papers citing papers by Henri Wichmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henri Wichmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Wichmann. The network helps show where Henri Wichmann may publish in the future.

Co-authorship network of co-authors of Henri Wichmann

This figure shows the co-authorship network connecting the top 25 collaborators of Henri Wichmann. A scholar is included among the top collaborators of Henri Wichmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henri Wichmann. Henri Wichmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bache, Matthias, Antje Güttler, Jacqueline Keßler, et al.. (2019). Evaluation of the Betulinic Acid–Cisplatin conjugate APC and its precursor DE9B for the treatment of human malignant glioma. Chemico-Biological Interactions. 314. 108841–108841. 6 indexed citations
2.
Weinholdt, Claus, Henri Wichmann, Johanna Kotrba, et al.. (2019). Prediction of regulatory targets of alternative isoforms of the epidermal growth factor receptor in a glioblastoma cell line. BMC Bioinformatics. 20(1). 434–434. 6 indexed citations
3.
Rot, Swetlana, Helge Täubert, Thomas Greither, et al.. (2019). Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients. BMC Cancer. 19(1). 12 indexed citations
4.
Riemann, Anne, Henri Wichmann, Jacqueline Keßler, et al.. (2019). Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells. Oncology Reports. 41(4). 2585–2594. 29 indexed citations
5.
Kappler, Matthias, Johanna Kotrba, Matthias Bache, et al.. (2017). P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients. Clinical and Translational Radiation Oncology. 5. 6–11. 26 indexed citations
6.
Riemann, Anne, Antje Güttler, Henri Wichmann, et al.. (2017). Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 26(2). 191–200. 21 indexed citations
7.
Kappler, Matthias, Swetlana Rot, Helge Täubert, et al.. (2016). Normoxic accumulation of HIF1α is associated with glutaminolysis. Clinical Oral Investigations. 21(1). 211–224. 29 indexed citations
8.
Bache, Matthias, Swetlana Rot, Jacqueline Keßler, et al.. (2015). mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma. Oncology Reports. 33(6). 3155–3161. 28 indexed citations
9.
Keßler, Jacqueline, Antje Güttler, Henri Wichmann, et al.. (2015). IDH1R132H mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status. Radiotherapy and Oncology. 116(3). 381–387. 34 indexed citations
10.
Bache, Matthias, et al.. (2015). Betulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells. International Journal of Molecular Sciences. 16(11). 26249–26262. 24 indexed citations
11.
Wichmann, Henri, Antje Güttler, Matthias Bache, et al.. (2014). Targeting of EGFR and HER2 with therapeutic antibodies and siRNA. Strahlentherapie und Onkologie. 191(2). 180–191. 21 indexed citations
12.
Wichmann, Henri, Antje Güttler, Matthias Bache, et al.. (2014). Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients. Strahlentherapie und Onkologie. 190(10). 912–918. 7 indexed citations
13.
Bache, Matthias, Stephan Bernhardt, Henri Wichmann, et al.. (2014). Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma—An in Vitro Study of Cytotoxicity and Radiosensitization. International Journal of Molecular Sciences. 15(11). 19777–19790. 32 indexed citations
14.
Güttler, Antje, Henri Wichmann, Jacqueline Keßler, et al.. (2013). Osteopontin and splice variant expression level in human malignant glioma: Radiobiologic effects and prognosis after radiotherapy. Radiotherapy and Oncology. 108(3). 535–540. 25 indexed citations
15.
Wichmann, Henri, Thomas Greither, Matthias Kappler, et al.. (2012). Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients. BMC Cancer. 12(1). 131–131. 23 indexed citations
16.
Zander, Thomas, Andrea Hofmann, Andrea Staratschek‐Jox, et al.. (2011). Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer. Clinical Cancer Research. 17(10). 3360–3367. 51 indexed citations
17.
Bache, Matthias, Jacqueline Keßler, Henri Wichmann, et al.. (2011). Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions. Radiation Oncology. 6(1). 111–111. 38 indexed citations
18.
Wichmann, Henri, Matthias Kappler, Matthias Kotzsch, et al.. (2010). Effects of osteopontin inhibition on radiosensitivityof MDA-MB-231 breast cancer cells. Radiation Oncology. 5(1). 82–82. 34 indexed citations
19.
Keßler, Jacqueline, Henri Wichmann, Swetlana Rot, et al.. (2010). HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. BMC Cancer. 10(1). 84 indexed citations
20.
Bache, Matthias, Matthias Kappler, Henri Wichmann, et al.. (2010). Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients. BMC Cancer. 10(1). 132–132. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antje Güttler Breakdown of academic impact, for papers by Maria Serena Roca Breakdown of academic impact, for papers by Filipa Lopes‐Coelho Breakdown of academic impact, for papers by Zengxia Li Breakdown of academic impact, for papers by Marike W. van Gisbergen Breakdown of academic impact, for papers by Ann Greer Breakdown of academic impact, for papers by Sonia Dolfi Breakdown of academic impact, for papers by Jacqueline Sayyah Breakdown of academic impact, for papers by Joon Hee Kang Breakdown of academic impact, for papers by Thomas H. Beckham
Rankless by CCL
2026